• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation.

作者信息

Reisberg B, Ferris S H, de Leon M J, Kluger A, Franssen E, Borenstein J, Alba R C

机构信息

Department of Psychiatry, New York University Medical Center, New York 10016.

出版信息

Prog Clin Biol Res. 1989;317:23-41.

PMID:2690101
Abstract

A series of studies published over the past 6 years now permit a relatively precise description of the temporal course of Alzheimer's disease (AD). Initially, 7 global stages of CNS aging and AD were described. Subsequently, data on the stage specific relationship between these stages and widely employed mental status, psychometric, and other assessment measures were collected. Longitudinal studies helped to clarify the borders between normal CNS aging and AD using these measures. Other studies described functioning and self-care correlates of the 7 global stages. These were ultimately divisible into 16 clearly defined, ordinal functional stages. Empirical longitudinal observations permitted the description of the mean temporal course of each of the 16 functional stages of aging and AD. The cross-sectional stage specific data on mental status and other measures can now be applied to the mean temporal course observations and the validity of the temporal estimates forwarded can be investigated in detail. Etiologic hypotheses based upon the observed phenomenologic and temporal course of AD are discussed.

摘要

相似文献

1
The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation.
Prog Clin Biol Res. 1989;317:23-41.
2
MRI and CSF studies in the early diagnosis of Alzheimer's disease.磁共振成像(MRI)和脑脊液研究在阿尔茨海默病早期诊断中的应用
J Intern Med. 2004 Sep;256(3):205-23. doi: 10.1111/j.1365-2796.2004.01381.x.
3
Depressive symptoms in Alzheimer's disease: natural course and temporal relation to function and cognitive status.阿尔茨海默病中的抑郁症状:自然病程以及与功能和认知状态的时间关系。
J Am Geriatr Soc. 2005 Dec;53(12):2083-9. doi: 10.1111/j.1532-5415.2005.00535.x.
4
Living alone with Alzheimer's disease: cross-sectional and longitudinal analysis in the REAL.FR Study.阿尔茨海默病患者独居情况:REAL.FR研究中的横断面与纵向分析
J Nutr Health Aging. 2005;9(2):117-20.
5
Neural networks for longitudinal studies in Alzheimer's disease.用于阿尔茨海默病纵向研究的神经网络。
Artif Intell Med. 2006 Mar;36(3):245-55. doi: 10.1016/j.artmed.2005.10.007. Epub 2006 Jan 19.
6
Longitudinal models of growth and survival applied to the early detection of Alzheimer's disease.应用于阿尔茨海默病早期检测的生长与生存纵向模型。
J Geriatr Psychiatry Neurol. 2005 Dec;18(4):234-41. doi: 10.1177/0891988705281879.
7
Predictors of cognitive change from preclinical to clinical Alzheimer's disease.从临床前到临床阿尔茨海默病认知变化的预测因素。
Brain Cogn. 2002 Jul;49(2):210-3.
8
Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role.可溶性CD40配体增强与阿尔茨海默病:可能致病作用的证据
Neurobiol Aging. 2008 Mar;29(3):348-56. doi: 10.1016/j.neurobiolaging.2006.10.019. Epub 2006 Nov 22.
9
Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.阿尔茨海默病中载脂蛋白Eε4相关认知衰退的个体生长曲线分析
Arch Neurol. 2005 Mar;62(3):454-9. doi: 10.1001/archneur.62.3.454.
10
White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease.白质病变普遍存在,但在衰老和早期阿尔茨海默病中与认知的关系存在差异。
Arch Neurol. 2005 Dec;62(12):1870-6. doi: 10.1001/archneur.62.12.1870.

引用本文的文献

1
Simple model systems reveal conserved mechanisms of Alzheimer's disease and related tauopathies.简单的模型系统揭示了阿尔茨海默病和相关tau 病的保守机制。
Mol Neurodegener. 2023 Nov 10;18(1):82. doi: 10.1186/s13024-023-00664-x.
2
Psychometric evaluation of the Pain Assessment in Advanced Dementia scale in an acute general hospital setting.在急性综合医院环境中,对高级痴呆症疼痛评估量表进行心理计量学评估。
Int J Geriatr Psychiatry. 2022 Dec;37(12). doi: 10.1002/gps.5830.
3
Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.
阿尔茨海默病的脑脊液生物标志物:当前证据与未来展望
Brain Sci. 2021 Feb 10;11(2):215. doi: 10.3390/brainsci11020215.
4
Exploiting Common Aspects of Obesity and Alzheimer's Disease.利用肥胖症和阿尔茨海默病的共同特征。
Front Hum Neurosci. 2020 Dec 15;14:602360. doi: 10.3389/fnhum.2020.602360. eCollection 2020.
5
European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment.欧洲神经病学会/欧洲阿尔茨海默病联合会关于轻度认知障碍患者的诊断披露、生物标志物咨询和管理的立场声明。
Eur J Neurol. 2021 Jul;28(7):2147-2155. doi: 10.1111/ene.14668. Epub 2020 Dec 23.
6
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease.脑脊髓液生物标志物水平:磷酸化 tau(T)和总 tau(N)作为阿尔茨海默病进展速度的标志物。
BMC Neurol. 2020 Jan 9;20(1):10. doi: 10.1186/s12883-019-1591-0.
7
Appetite, Metabolism and Hormonal Regulation in Normal Ageing and Dementia.正常衰老和痴呆中的食欲、代谢与激素调节
Diseases. 2018 Jul 20;6(3):66. doi: 10.3390/diseases6030066.
8
Dependence Stage and Pharmacoeconomic Outcomes in Patients With Alzheimer Disease.阿尔茨海默病患者的依赖阶段与药物经济学结果
Alzheimer Dis Assoc Disord. 2017 Jul-Sep;31(3):209-217. doi: 10.1097/WAD.0000000000000198.
9
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death.胆碱酯酶抑制剂不会改变阿尔茨海默病患者在养老院的住院时长:一项关于影响从入院到死亡生存时间的因素的前瞻性观察研究。
BMC Neurol. 2016 Aug 31;16(1):156. doi: 10.1186/s12883-016-0675-3.
10
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.阿尔茨海默病轻度与中度阶段:胆碱酯酶抑制剂治疗常规临床环境中的三年结局
Alzheimers Res Ther. 2016 Feb 17;8:7. doi: 10.1186/s13195-016-0174-1.